Observation of the Efficacy and Tolerance of Motens® (Lacidipine) in Patients With Essential Hypertension

NCT02235415 · clinicaltrials.gov ↗

COMPLETED

Status

24526

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Motens® (lacidipine)

Sponsor

Boehringer Ingelheim